Stay updated on Pembrolizumab for Leptomeningeal Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.

Latest updates to the Pembrolizumab for Leptomeningeal Disease Clinical Trial page
- Check6 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, with guidance to check cc.nih.gov and opm.gov for updates. The page revision version was updated from 3.4.0 to 3.4.1.SummaryDifference0.5%

- Check13 days agoChange DetectedThe changes are minor UI and metadata updates, including the addition of a Show glossary option and revision/version labels, as well as small wording/capitalization adjustments to several fields; these do not alter core trial content or patient-facing information. There are no changes to the study details, eligibility criteria, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows a revision updated from v3.3.3 to v3.3.4, with the previous revision label removed and the new revision added. This is a metadata update and does not alter study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedLocations section added with Maryland listed as a site, updating where the trial is conducted. The page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check78 days agoChange DetectedThe Publications section now states that publications are automatically filled in from PubMed, and the page revision label shows Revision: v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe funding-status notice was removed from the page, and the study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Leptomeningeal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.